Causeway Sensors Limited

Exhibitor

To accelerate and improve the production of new and existing drug therapies, quantifying the concentration of antibody produced in bioprocesses is a critical need for researchers and manufacturers alike. Causeway Sensors, a spinout of Queen's University Belfast, has commercialised their novel nanostructured sensing platform, TITAN, to answer this challenge.

Leveraging a driven, multi-disciplinary team, Causeway Sensors has built on the foundation of academic excellence that originally propelled the innovation to spin out by adding expertise in biology, chemistry, product design, data science and software engineering, all to make sure that TITAN accurately and reliably answers the needs of the industry.